Ftse Mib
34.492,41
0,13%
DAX
18.497,94
-0,09%
S&P 500
5.277,51
0,80%
NASDAQ
16.735,02
-0,01%
Bitcoin
67.750,55
0,40%
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Syndax Pharmaceuticals Inc (SNDX) Syndax Pharmaceuticals Inc (SNDX) Notizie

Syndax Pharmaceuticals Inc

SNDX
19,27
-0,02 (-0,10%)
01 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
16/5/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202422:03EDGAR2Form 3 - Initial statement of beneficial ownership of..
15/5/202422:11EDGAR2Form 8-K - Current report
15/5/202422:05PRNUSSyndax Pharmaceuticals Appoints Aleksandra Rizo, M.D., Ph.D...
09/5/202413:00PRNUSSyndax Announces Participation at the Bank of America..
08/5/202413:06PRNUSSyndax Pharmaceuticals Reports First Quarter 2024 Financial..
08/5/202413:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202413:03EDGAR2Form 8-K - Current report
03/5/202422:05PRNUSSyndax Pharmaceuticals Reports Inducement Grants Under..
01/5/202413:00PRNUSSyndax to Announce First Quarter 2024 Financial Results and..
10/4/202422:05PRNUSSyndax Announces Participation at the Stifel 2024 Virtual..
08/4/202413:00PRNUSSyndax Presents Positive Pediatric Data from Pivotal..
05/4/202422:05PRNUSSyndax Pharmaceuticals Reports Inducement Grants Under..
28/3/202412:00PRNUSSyndax Announces Completion of Enrollment in AUGMENT-101..
26/3/202421:05PRNUSSyndax Announces FDA Priority Review of NDA for Revumenib..
18/3/202412:00PRNUSSyndax Announces Appointment of Steven Closter as Chief..
01/3/202422:05PRNUSSyndax Pharmaceuticals Reports Inducement Grants Under..
27/2/202423:28EDGAR2Form S-3ASR - Automatic shelf registration statement of..
27/2/202423:21EDGAR2Form S-8 - Securities to be offered to employees in employee..
27/2/202422:05PRNUSSyndax Pharmaceuticals Reports Fourth Quarter and Full Year..
27/2/202422:03EDGAR2Form 8-K - Current report
26/2/202413:00PRNUSSyndax Announces Participation at Two Upcoming Investor..
20/2/202422:05PRNUSSyndax to Announce Fourth Quarter and Year-end 2023..
14/2/202418:50EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202413:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202403:44EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202422:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:05PRNUSSyndax Pharmaceuticals Reports Inducement Grants Under..
01/2/202422:10PRNUSSyndax Announces Participation at Two Upcoming Investor..
05/1/202422:05PRNUSSyndax Pharmaceuticals Reports Inducement Grants Under..
02/1/202422:05PRNUSSyndax Announces Presentation at 42nd Annual J.P. Morgan..
02/1/202413:00PRNUSSyndax Highlights Recent Updates and Anticipated 2024..
20/12/202314:40EDGAR2Form 8-K - Current report
19/12/202322:16PRNUSSyndax Announces Closing of Public Offering of Common Stock..
15/12/202323:29EDGAR2Form 8-K - Current report
15/12/202323:29EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
15/12/202305:07PRNUSSyndax Announces Pricing of $200 Million Public Offering of..
14/12/202322:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/12/202322:00PRNUSSyndax Announces Proposed $150 Million Public Offering of..
12/12/202322:05EDGAR2Form 8-K - Current report
12/12/202318:00PRNUSSyndax Presents Positive Data from Pivotal AUGMENT-101 Trial..
11/12/202313:30PRNUSSyndax Announces Positive Data for Revumenib in Patients..
11/12/202312:33BWIncyte und Syndax präsentieren bei ASH-Plenarsitzung weitere..
10/12/202323:00BWIncyte and Syndax Present Additional Data from Positive..
Apertura: 19,45 Min: 19,155 Max: 19,785
Chiusura: 19,29

La tua Cronologia

NASDAQ
SNDX
Syndax Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network